Breaking News

Hydrofarm Holdings Group (NASDAQ: HYFM) announced their fourth-quarter 2023 financial results on February 29, 2024. The company reported a GAAP...

GH Research experienced a significant setback in the second quarter of 2023, reporting a net loss of $(7.7) million, or...

On February 29, 2024, Barclays analyst David Anderson made some adjustments to his rating and price target for Oceaneering International....

Xometry is projecting a strong start to the year, with expected revenue in Q1 2024 ranging from $118 million to...

Analyst Rob Oliver from Baird has boosted Salesforce (NYSE:CRM) from a "neutral" to an "outperform" rating on February 29, 2024....

Advantage Solutions (NASDAQ: ADV) disappointed investors with quarterly earnings of $0.05 per share on February 29, 2024, missing the analyst...

TriSalus Life Sciences has recently unveiled a groundbreaking study highlighting the remarkable effectiveness of the TriNav device in treating patients...

Amarin has announced plans to repurchase up to $50 million worth of shares by the end of Q2 2024, pending...

Colleen Kusy, an analyst at Baird, has decided to keep a Neutral rating on Mersana Therapeutics (NASDAQ:MRSN) but has increased...

Endava (NYSE:DAVA) announced its Q2 FY2024 adjusted earnings of $0.37 per share on February 29, 2024, exceeding the analyst consensus...